首页> 美国卫生研究院文献>Journal of Transplantation >Attitudes to Medication after Kidney Transplantation and Their Association with Medication Adherence and Graft Survival: A 2-Year Follow-Up Study
【2h】

Attitudes to Medication after Kidney Transplantation and Their Association with Medication Adherence and Graft Survival: A 2-Year Follow-Up Study

机译:肾脏移植后对药物的态度及其与药物依从性和移植物存活的关系:一项为期两年的随访研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Background. Nonadherence to medication is a common problem after kidney transplantation. The aim of this study was to explore attitudes towards medication, adherence, and the relationship with clinical outcomes. Method. Kidney recipients participated in a Q-methodological study 6 weeks after transplantation. As a measure of medication adherence, respondents completed the Basel Assessment of Adherence to Immunosuppressive Medications Scale (BAASIS©-interview). Moreover, the intrapatient variability in the pharmacokinetics of tacrolimus was calculated, which measures stability of drug intake. Data on graft survival was retrieved from patient records up to 2 years after transplantation. Results. 113 renal transplant recipients (19–75 years old) participated in the study. Results revealed three attitudes towards medication adherence—attitude 1: “confident and accurate,” attitude 2: “concerned and vigilant,” and attitude 3: “appearance oriented and assertive.” We found association of attitudes with intrapatient variability in pharmacokinetics of tacrolimus, but not with self-reported nonadherence or graft survival. However, self-reported nonadherence immediately after transplantation was associated with lower two-year graft survival. Conclusion. These preliminary findings suggest that nonadherence shortly after kidney transplantation may be a risk factor for lower graft survival in the years to follow. The attitudes to medication were not a risk factor.
机译:背景。肾脏移植后不遵守药物治疗是一个普遍的问题。这项研究的目的是探讨对药物治疗,依从性以及与临床结局的关系。方法。肾脏接受者在移植后6周参加了一项Q-方法学研究。作为对药物依从性的一种度量,受访者完成了《巴塞尔免疫抑制药物依从性评估量表》(BAASIS ©-访谈)。此外,计算了他克莫司药代动力学的患者体内变异性,以衡量药物摄入的稳定性。从移植后长达2年的患者记录中获取移植物存活的数据。结果。 113位肾移植受者(19-75岁)参加了该研究。结果显示出对药物依从性的三种态度:态度1:“自信而准确”;态度2:“关注和警惕”;态度3:“注重外观和果断”。我们发现态度与他克莫司药代动力学中患者的变异性有关,但与自我报告的不依从性或移植物存活无关。然而,移植后立即自我报告的不依从性与较低的两年移植物存活率有关。结论。这些初步发现表明,肾移植后不久的不依从性可能是随后几年移植物存活率降低的危险因素。对药物的态度不是危险因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号